Labiotech.eu

In Depth 8 Jun 2020

Regulations on Genetic Data Could Threaten Genomics Innovation

As genetic research relies more and more on digital technology, international regulations are straining to catch up and some fear they threaten to stifle innovation. Is it possible to develop a regulatory framework for genetic data that is fair for everyone? In just a couple decades, the digital revolution has taken over all sorts of […]

June 8, 2020 - 6 minutesmins - By External Contributor

News and Trends 6 Jun 2020

Boost For Inflammatory Disease Biotech NodThera With €49M Series B

The UK-US biotech NodThera has raised €48.7M in Series B funding to progress its drug candidate through clinical trials for the treatment of inflammatory conditions such as inflammatory bowel disease. This round follows an impressive €32M Series A that Nodthera carried out in 2018. Danish firm Novo Ventures, part of the investment arm of Novo […]

June 6, 2020 - 3 minutesmins - By Helen Albert

News and Trends 5 Jun 2020

Upsized Nasdaq IPO Yields Calliditas €80M to Commercialize Kidney Drug

Swedish company Calliditas Therapeutics has raised an €80M IPO on the Nasdaq Global Select Market — 20% above its initial target — to fund an ongoing phase III trial of its lead candidate treatment for an inflammatory kidney condition. Calliditas plans to use the net proceeds together with its existing cash resources to fund an […]

June 5, 2020 - 2 minutesmins - By Laura Cowen

huntingtons disease dementia prilenia therapeutics

News and Trends 5 Jun 2020

Israeli-Dutch Biotech Raises €55M to Fight Huntington’s Disease and ALS

Prilenia Therapeutics has raised €55M in Series A funding to launch late-stage clinical trials of its small molecule candidate drug in Huntington’s disease and amyotrophic lateral sclerosis, incurable conditions that have very limited treatment options. Dutch life sciences VC Forbion led the round and was joined by new Chinese investor Morningside Venture Investments and the […]

June 5, 2020 - 3 minutesmins - By Helen Albert

News and Trends 4 Jun 2020

Update: Fifth US Antibody Patent Owned by UK Biotech Upheld in Regeneron Battle

Update (04/06/2020): After upholding four of Kymab’s patents addressing the production of antibody drugs earlier this year, the US Patent Trial and Appeal Board has rejected Regeneron’s attempt to invalidate a fifth patent regarding the same technology. So far, Regeneron has not requested a re-hearing from the Board regarding the decision to uphold Kymab’s first […]

June 4, 2020 - 4 minutesmins - By Anita Chakraverty

Expert Advice 4 Jun 2020

The Beginner’s Guide to Biotech & Life Science Marketing

As life science professionals, we not only continuously handle hard science and research, but we also have to learn how to market our products and interact with a large online audience. However, coming from the sciences, many of us struggle with bio-business. Here is where you can start. In this article, we will take you […]

June 4, 2020 - 13 minutesmins - By Letícia Manosso

News and Trends 3 Jun 2020

What Did European Oncology Players Offer at ASCO 2020?

Despite widespread clinical trial delays caused by the coronavirus pandemic, many oncology biotechs have been able to continue their fight against cancer. With advances in CAR T-cell therapies, cancer vaccines, RNA drugs, and more, European companies held a strong presence at the American Society of Clinical Oncology (ASCO) this year. The huge ASCO conference has […]

June 3, 2020 - 10 minutesmins - By Jonathan Smith

In Depth 1 Jun 2020

How Personal Genomics Companies Are Changing Drug Development

In recent years, companies offering direct-to-consumer genomics tests have started switching the business model and venturing into drug development. Amidst criticism on data protection and lack of transparency, personal genomics companies are leveraging their unique position to generate genomics data to strike lucrative deals with pharma companies. Thanks to cheaper data acquisition and convenient analysis, […]

June 1, 2020 - 6 minutesmins - By Timothé Cynober

News and Trends 29 May 2020

AI Drug Discovery Firm Exscientia Closes €54M Series C

UK-based Exscientia has closed a Series C financing round of €54M ($60M) to develop its artificial intelligence (AI) technology to guide drug discovery. The Danish investor Novo Holdings led the round with its first investment in the company. Additional funding also came from existing investors including drug development company Evotec and Chinese VC firm GT […]

May 29, 2020 - 3 minutesmins - By David Kirk

News and Trends 29 May 2020

Argenx Follows up Phase III Success with Giant €785M Global Offering

The Dutch biotech argenx has cashed in on recent positive phase III results by launching an enormous €784.7M ($862.5M) global share offering. Argenx’s fundraise swiftly follows the announcement of phase III trial results earlier this week, where its lead candidate antibody drug, efgartigimod, improved motor symptoms of patients with the chronic autoimmune disease myasthenia gravis. […]

May 29, 2020 - 2 minutesmins - By Jonathan Smith

central nervous system epilepsy parkinsons disease

News and Trends 29 May 2020

Spanish Neurology Biotech Launches with €7.6M Series A

Accure Therapeutics, a neurology biotech targeting central nervous system (CNS) conditions such as multiple sclerosis and Parkinson’s disease, has launched in Barcelona with a Series A of €7.6M. Alta Life Sciences, a life science venture capital firm based in the same city, and the Spanish governmental institution The Centre for Technological and Industrial Development funded […]

May 29, 2020 - 3 minutesmins - By Helen Albert

News and Trends 28 May 2020

French Startup Secures €2.3M to Advance Cancer RNA Immunotherapy

Lyon-based biopharmaceutical company Tollys has closed a Series A funding round of €2.3M to bring its lead RNA immunotherapy candidate to clinical trials in people with bladder cancer. The round was closed on the basis of the company reaching preclinical proof-of-concept for the drug. It brings the total amount raised by Tollys to €6.4M since […]

May 28, 2020 - 2 minutesmins - By Laura Cowen

Knowledge hub

Categories

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Regulations on Genetic Data Could Threaten Genomics Innovation

Boost For Inflammatory Disease Biotech NodThera With €49M Series B

Upsized Nasdaq IPO Yields Calliditas €80M to Commercialize Kidney Drug

Israeli-Dutch Biotech Raises €55M to Fight Huntington’s Disease and ALS

Update: Fifth US Antibody Patent Owned by UK Biotech Upheld in Regeneron Battle

The Beginner’s Guide to Biotech & Life Science Marketing

What Did European Oncology Players Offer at ASCO 2020?

How Personal Genomics Companies Are Changing Drug Development

AI Drug Discovery Firm Exscientia Closes €54M Series C

Argenx Follows up Phase III Success with Giant €785M Global Offering

Spanish Neurology Biotech Launches with €7.6M Series A

French Startup Secures €2.3M to Advance Cancer RNA Immunotherapy

Subscribe to our newsletter to get the latest biotech news!

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Webinar: Organoids in cancer research - Paving the way for faster drug development across cancer indications

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!